Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.

Michael N PassarelliElizabeth L BarryJudy R ReesLeila A MottDennis J Ahnen John A Baron

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)

Aspirin dosing strategies accounting for body weight suggested in previous trials of colorectal cancer may not apply to adenomas.

Keyphrases

body composition
body weight
low dose
cardiovascular events
resistance training
antiplatelet therapy
bone mineral density
anti inflammatory drugs
acute coronary syndrome
type diabetes